Peptide Tag Composition to Reduce Cytoplasmic Protein Aggregation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Intracellular antibodies and proteins face stability issues due to aggregation in the cytoplasm, leading to reduced expression levels and functional inhibition, with existing peptide tags containing 45% or more acidic amino acids focusing on endosomal pH rather than cytoplasmic pH.

Innovation Solution

A peptide tag with 5% to 45% acidic amino acids and 20% to 70% of F, P, Y, G, S, Q, N, and A amino acids, along with limited M, T, W, C, I, V, and L, reduces aggregation by optimizing for cytoplasmic stability.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If an antibody is expressed in the cytoplasm, then intracellular antibody function is achieved, but aggregation occurs leading to reduced stability and expression level

Engineering Contradiction:
Improveintracellular antibody functionVSAvoidantibody stability in cytoplasm
Core Design Contradiction:
ReliabilityVSStability of the object's composition

Solution Approach 1:

A peptide tag is introduced as an intermediary component between the antibody and the cytoplasmic environment. This peptide tag, with specifically optimized amino acid composition (5-45% acidic amino acids and 20-70% F, P, Y, G, S, Q, N, A), acts as a mediator that prevents aggregation of the antibody in the cytoplasm while allowing the antibody to maintain its intracellular function. The peptide tag absorbs the harmful interaction between the antibody and the cytoplasmic environment.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Adaptability or versatility

If existing peptide tags with 45% or more acidic amino acids are used, then endosomal pH optimization is achieved, but cytoplasmic aggregation is not sufficiently prevented

Engineering Contradiction:
Improveendosomal pH adaptationVSAvoidcytoplasmic aggregation prevention
Core Design Contradiction:
Adaptability or versatilityVSStability of the object's composition

Solution Approach 1:

The amino acid composition parameters of the peptide tag are fundamentally changed from the conventional design (≥45% acidic amino acids optimized for endosomal pH) to a new parameter range (5-45% acidic amino acids with 20-70% F, P, Y, G, S, Q, N, A). This parameter change shifts the optimization focus from endosomal pH environment to cytoplasmic stability, thereby preventing aggregation in the cytoplasm while maintaining adequate adaptability.

Inventive Principle:
Principle #35Parameter changes

3Stability of the object's composition

If protein aggregation is reduced, then intracellular stability is improved, but expression level must be maintained

Engineering Contradiction:
Improveintracellular protein stabilityVSAvoidprotein expression level
Core Design Contradiction:
Stability of the object's compositionVSProductivity

Solution Approach 1:

The peptide tag with optimized amino acid composition provides self-service functionality by automatically preventing aggregation of the fused protein in the cytoplasm. This aggregation prevention mechanism inherently maintains protein stability and expression levels without requiring additional external interventions or complex systems. The peptide tag serves itself to solve the aggregation problem while preserving productivity.

Inventive Principle:
Principle #25Self-service

Data Source

PatentUS20250258180A1Peptide tag and nucleic acid encoding same
Publication Date: 2025.08.14 STAND THERAPEUTICS CO LTD
  • US20250258180A1 patent drawing
  • US20250258180A1 patent drawing
  • US20250258180A1 patent drawing

AI summary

The present disclosure provides a peptide tag, and a nucleic acid encoding the peptide tag. The peptide tag of the present disclosure can reduce an aggregation property of a protein in a cell. Specifically, the peptide tag of the present disclosure can be a peptide tag in which 5% or more and less than 45% of amino acids contained in an amino acid sequence thereof are acidic amino acids, and (b) 20% or more of the amino acids contained in the amino acid sequence are amino acids selected from the group consisting of F, P, Y, G, S, Q, N, and A.